Thyroid Cancer, Nonmedullary, 2 (NMTC2)

Thyroid Cancer, Nonmedullary, 2(来自ICD-11)

别称:

Thyroid Carcinoma, Follicular

Follicular Thyroid Carcinoma

Nmtc2

Moderately Differentiated Follicular Carcinoma of Thyroid Gland

Well Differentiated Follicular Carcinoma of Unspecified Site

Well Differentiated Follicular Carcinoma of Thyroid Gland

Pure Follicle Follicular Carcinoma of Unspecified Site

Trabecular Follicular Carcinoma of Unspecified Site

Trabecular Follicular Carcinoma of Thyroid Gland

Pure Follicular Carcinoma of Thyroid Gland

Follicular Carcinoma of Unspecified Site

Pure Follicle Carcinoma of Thyroid Gland

Thyroid Carcinoma, Follicular, Somatic

Cancer, Thyroid, Nonmedullary, Type 2

Thyroid Cancer, Non-Medullary, 2

Thyroid Follicular Carcinoma

Thyroid Gland Adenocarcinoma

Thyroid Cancer, Follicular

Follicular Thyroid Cancer

加入收藏

Basic Information

Medical Symptom

Gene & Mutation

Related Drugs

Disease Model

References Literature

Thyroid Cancer, Nonmedullary, 2, also known as thyroid carcinoma, follicular, is related to differentiated thyroid carcinoma and hypothyroidism, congenital, nongoitrous, 1. An important gene associated with Thyroid Cancer, Nonmedullary, 2 is SRGAP1 (SLIT-ROBO Rho GTPase Activating Protein 1), and among its related pathways/superpathways are Signal Transduction and Phospholipase-C Pathway. The drugs Sunitinib and Romidepsin have been mentioned in the context of this disorder. Affiliated tissues include thyroid and lung, and related phenotypes are follicular thyroid carcinoma and papillary thyroid carcinoma

查看原文参与反馈